NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $589,000 | +6.9% | 34,661 | +4.2% | 0.01% | -11.1% |
| Q3 2020 | $551,000 | -27.9% | 33,261 | +0.9% | 0.01% | -35.7% |
| Q2 2020 | $764,000 | +33.8% | 32,961 | +3.1% | 0.01% | +16.7% |
| Q1 2020 | $571,000 | -17.2% | 31,961 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $690,000 | +19.2% | 31,961 | +0.6% | 0.01% | +9.1% |
| Q3 2019 | $579,000 | -47.9% | 31,761 | +1.6% | 0.01% | -47.6% |
| Q2 2019 | $1,112,000 | +7.9% | 31,261 | +1.9% | 0.02% | +5.0% |
| Q1 2019 | $1,031,000 | +7.7% | 30,692 | +5.5% | 0.02% | -9.1% |
| Q4 2018 | $957,000 | -45.9% | 29,100 | +0.3% | 0.02% | -35.3% |
| Q3 2018 | $1,768,000 | +25.3% | 29,000 | +0.3% | 0.03% | +17.2% |
| Q2 2018 | $1,411,000 | – | 28,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |